About Genome Life Sciences
Genome Life Sciences is a Healthcare company based in Chennai (India) founded in 2004 by Periannan Senapathy. It delivers comprehensive services for next-generation sequencing and big data analysis in life sciences. It operates on a B2B model. The company has 30 employees. Its chief executive, as recorded, is Periannan Senapathy. Its Indian entity Genome International India Private Limited reported revenue of ₹3.08 Cr. Its focus areas include Biotechnology, Genomics and Sequencing Services.
Company details
Genome Life Sciences delivers comprehensive services for next-generation sequencing and big data analysis in life sciences through providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and sequencing services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
- Headquarters Chennai, India
- Employees 30
- Founders Periannan Senapathy
- SectorsHealthcare
- Website genomels.com
- Social Facebook
- Legal Name Genome International India Private Limited
- Date of Incorporation 09 Jul, 2004
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹3.08 Cr
FY 2024 · -9% YoY
- Net Loss-₹11.7 Lakh
FY 2024 · -4% margin
- EBITDA-₹4.5 Lakh
FY 2024 · -1% margin
- Employee Count30
Associated legal entities of Genome Life Sciences
Genome Life Sciences operates through Genome International India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genome International India Private Limited CIN U73100TN2004PTC053684 | Active | 09 Jul 2004 | Chennai, Tamil Nadu | ₹3.1 Cr | 30 | 2 | View details |
Board of directors of Genome International India Private Limited (Genome Life Sciences)
Genome International India Private Limited is the primary company behind Genome Life Sciences. The board of Genome International India Private Limited currently have 2 directors; the longest-serving is Periannan Senapathy, appointed in 2004. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Periannan Senapathy DIN 02238673 | Director | 09 Jul 2004 | 22 yrs 3 mo | Genome International India Private Limited |
| Abarajeetha Rajendran DIN 06516459 | Director | 09 Aug 2023 | 3 yrs 2 mo | Genome International India Private Limited |
People of Genome Life Sciences
1 people are tracked at Genome Life Sciences (1 in leadership); the tracked headcount is 30.
| Name | Role | Group |
|---|---|---|
| Founder, CEO | Leadership |
Complete people profiles for Genome Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Genome Life Sciences
Figures of Genome International India Private Limited, the primary company behind Genome Life Sciences, for FY 2024. Revenue was ₹3.08 Cr (-9% year on year). Net loss was -₹11.7 Lakh (-4% margin). EBITDA was -₹4.5 Lakh (-1% margin). Revenue has grown at a compounded annual rate of +1% over three years and +5% over five years.
- ₹3.08 CrRevenue · FY 2024 · -9% YoY
- -₹11.7 LakhNet loss · -4% margin
- -₹4.5 LakhEBITDA · -1% margin
- ₹1 LakhPaid-up capital
- 30Employees (provident fund records)
- +1%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Genome International India Private Limited are on its company page.
Detailed financial statements for Genome Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genome Life Sciences
Genome Life Sciences was founded in 2004.
Genome Life Sciences is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Periannan Senapathy is the CEO of Genome Life Sciences, as recorded in our data. They have also founded this company.
Genome Life Sciences has 30 employees.
The primary company behind Genome Life Sciences, Genome International India Private Limited, reported revenue of ₹3.08 Cr for FY 2024, down 9% year on year.
Genome Life Sciences delivers comprehensive services for next-generation sequencing and big data analysis in life sciences through providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and sequencing services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Genome Life Sciences operates through Genome International India Private Limited.
The legal entities of Genome Life Sciences currently have 2 directors, including Periannan Senapathy, Abarajeetha Rajendran.